Lakefront Biotherapeutics
LKFT
#5021
Rank
S$2.46 B
Marketcap
S$37.62
Share price
-0.34%
Change (1 day)
N/A
Change (1 year)

Earnings for Lakefront Biotherapeutics (LKFT)

Earnings in 2026 (TTM): S$0.71 Billion

According to Lakefront Biotherapeutics's latest financial reports the company's current earnings are S$1.22 Billion. In 2025 the company made an earning of S$0.47 Billion, an increase over its 2024 earnings that were of -S$7.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lakefront Biotherapeutics from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.71 B49.51%
2025 S$0.47 B-6464.81%
2024 -S$7.47 Million-82.77%
2023 -S$43.32 Million-85.59%
2022 -S$0.31 Billion60.71%
2021 -S$0.19 Billion-60.08%
2020 -S$0.47 Billion-331.44%
2019 S$0.20 B-523.76%
2018 -S$47.79 Million-72.34%
2017 -S$0.18 Billion-329.59%
2016 S$75.25 M-144.3%
2015 -S$0.17 Billion